Jove
Visualize
Contact Us

Related Experiment Videos

Melanoma lymphoscintigraphy and lymphatic mapping.

C G Berman1, J Choi, M R Hersh

  • 1H. Lee Moffitt Cancer Center, Department of Radiology, Tampa, FL 33612, USA.

Seminars in Nuclear Medicine
|February 3, 2000
PubMed
Summary

Lymphoscintigraphy accurately identifies sentinel lymph nodes (SLN) at risk for melanoma metastasis. This lymphatic mapping technique enables precise SLN identification and sampling for highly sensitive melanoma detection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Probing Small Bjorken-x Nuclear Gluonic Structure via Coherent J/ψ Photoproduction in Ultraperipheral Pb-Pb Collisions at sqrt[s_{NN}]=5.02  TeV.

Physical review letters·2024
Same author

Health and job-related factors associated with work ability in older working populations of Korea.

Occupational medicine (Oxford, England)·2023
Same author

Measurement of the top quark mass using a profile likelihood approach with the lepton + jets final states in proton-proton collisions at <math></math>.

The European physical journal. C, Particles and fields·2023
Same author

Observation of τ Lepton Pair Production in Ultraperipheral Pb-Pb Collisions at sqrt[s_{NN}]=5.02  TeV.

Physical review letters·2023
Same author

A search for decays of the Higgs boson to invisible particles in events with a top-antitop quark pair or a vector boson in proton-proton collisions at <math></math>.

The European physical journal. C, Particles and fields·2023
Same author

Measurement of the Dependence of the Hadron Production Fraction Ratios f_{s}/f_{u} and f_{d}/f_{u} on B Meson Kinematic Variables in Proton-Proton Collisions at sqrt[s]=13  TeV.

Physical review letters·2023
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Oncology
  • Nuclear Medicine
  • Dermatology

Background:

  • Melanoma metastasis risk assessment is crucial for patient management.
  • Identifying regional lymph node involvement is key to staging melanoma.
  • Sentinel lymph node (SLN) biopsy is a standard procedure for staging melanoma.

Purpose of the Study:

  • To evaluate the reliability of lymphoscintigraphy in identifying melanoma SLNs.
  • To highlight the predictive value of SLN status for regional metastasis.
  • To emphasize the benefits of selective lymph node sampling in melanoma staging.

Main Methods:

  • Lymphatic mapping using lymphoscintigraphy to identify the SLN.
  • Selective sampling of the identified SLN for pathological examination.

Related Experiment Videos

  • Comparison of pathological examination sensitivity with conventional methods.

    • Main Results:

    • Lymphoscintigraphy is a reliable method for identifying SLNs in melanoma patients.
    • The metastatic status of the SLN predicts the status of the entire regional lymph node basin.
    • Selective lymph node sampling offers significantly higher sensitivity (up to 100x) for melanoma detection compared to conventional examinations.

    Conclusions:

    • Lymphoscintigraphy and SLN biopsy are effective for accurate melanoma staging.
    • Selective lymph node sampling enhances diagnostic sensitivity and reduces invasiveness.
    • This approach improves the comprehensive pathological examination of high-risk tissue in melanoma.